Indefinite Delivery Contract SPE2DB25D9757

The federal government has awarded an Indefinite Delivery Contract (IDC) valued at $499,999,999 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, awarded by the Defense Logistics Agency (DLA) under the SPE2DB program, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities nationwide.

The IDC enables the DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This contract positions DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites. The contract is valid through November 2026 and does not have any set-aside designations, allowing the company to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.